Waverley Pharma Inc V.WAVE

Healthcare Biotechnology

Waverley Pharma Inc. is a biopharmaceutical company engaged in the research, development, and commercialization of human therapeutics focused on oncology. Its primary focus is the PARP-1 program and secondary focus is the generic oncology injectable market in European Union, the United Kingdom (UK) and North America. It has entered into a license, manufacture, supply, marketing and distribution agreement with Reliance Life Sciences Private Limited, which has granted it an exclusive territorial license to market and sell capecitabine in the UK and Germany as well as a non-exclusive territorial license to market and sell temozolomide and erlotinib in the UK. Its generic oncology products include bortezomib and pemetrexed. Bortezomib is an injectable generic chemotherapy drug, developed for the treatment of multiple myeloma and mantle cell lymphoma. Pemetrexed is an injectable generic chemotherapy drug, developed for the treatment of non-small cell lung cancer and pleural mesothelioma.

TSXV:WAVE - Post by User

Waverley Pharma Inc > bottom in at .23

<< Previous

Bullboard Posts

Next >>

Comment by yixteron Aug 01, 2020 8:26am

109 Views

Post# 31353360

RE:RE:RE:RE:RE:RE:RE:bottom in at .23

I was buying at .23 yesterday and if it dips at all I will buy again the setup here is great even if they do a pp those shares are wrapped up for four months the float remains ultra tight. There are no warrants out at present so no matter the situation the runway stays clear for the next several months.

<< Previous

Bullboard Posts

Next >>

Walmart stock and revenue both on the rise